Eastern Cooperative Oncology Group: Kidney Neoplasms trials
The registry lists 10 Kidney Neoplasms studies with Eastern Cooperative Oncology Group as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 8Phase 3 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerCompletedNCT00077129Phase 2
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00053209Phase 2
- Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00039429Phase 2
- Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00005966Phase 3
- Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionCompletedNCT00005644Phase 2
- Carboxyamidotriazole in Treating Patients With Advanced Kidney CancerCompletedNCT00005045Phase 2
- Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerCompletedNCT00004223Phase 2
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3
- Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 2
- Piritrexim in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00002914Phase 2